VON WILLEBRAND DISEASE (VWD)
Clinical trials for VON WILLEBRAND DISEASE (VWD) explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD) trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bleeding disorder: Long-Term drug shows promise
Disease control CompletedThis study tested a drug called rVWF (Vonvendi) in 38 children and adults with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular use of the drug could reduce the number of spontaneous bleeding episodes over a year. Participants received treatment …
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
UK doctors look back at real-world use of new VWD drug
Knowledge-focused CompletedThis study looked back at medical records of 34 adults with von Willebrand disease (VWD) in the UK who received a newer treatment called vonicog alfa (rVWF). The goal was to see how well it controlled bleeding and was used during surgeries in real-world settings. No new treatment…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC